Literature DB >> 3706932

Impotence in scleroderma.

N S Nowlin, J E Brick, D J Weaver, D A Wilson, H L Judd, J K Lu, H E Carlson.   

Abstract

Hormonal, neurologic, and vascular factors affecting potency were evaluated in 10 men with scleroderma and in 10 age-matched men with rheumatoid arthritis. Impotence was reported by 6 of the patients with scleroderma and none with rheumatoid arthritis. Studies of serum testosterone, free testosterone index, follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, thyroxine, and thyrotropin did not show a hormonal basis for impotence in any patient. Neurologic causes were not found on physical examination. Penile blood pressures were markedly abnormal in 4 impotent patients, intermediate in 2 impotent and 3 potent patients, and normal in 11 potent patients. A history of claudication and diminished ankle blood pressures indicated large vessel disease in 2 impotent patients; the remaining 4 impotent men had normal ankle pressures, suggesting that their poor penile blood pressures and impotence were due to small vessel disease, perhaps the small artery lesions of scleroderma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3706932     DOI: 10.7326/0003-4819-104-6-794

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  11 in total

1.  Peyronie's disease in systemic sclerosis.

Authors:  J Ordi; A Selva; V Fonollosa; M Vilardell; R Jordana; C Tolosa
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

Review 2.  Erectile Dysfunction in Systemic Sclerosis.

Authors:  Veronika K Jaeger; Ulrich A Walker
Journal:  Curr Rheumatol Rep       Date:  2016-08       Impact factor: 4.592

3.  Progressive systemic sclerosis and IgA deficiency in a young man.

Authors:  C Veen; A J Swaak
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

4.  The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis.

Authors:  Predrag Ostojic; Nemanja Damjanov
Journal:  Clin Rheumatol       Date:  2007-02-10       Impact factor: 2.980

5.  Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis.

Authors:  Sapol Thepwiwatjit; Suranut Charoensri; Wichien Sirithanaphol; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Chingching Foocharoen
Journal:  J Scleroderma Relat Disord       Date:  2022-07-24

6.  Vascular alterations and sexual function in systemic sclerosis.

Authors:  Ann Julie Impens; James R Seibold
Journal:  Int J Rheumatol       Date:  2010-08-05

Review 7.  The autonomic nervous system in systemic sclerosis. A review.

Authors:  Luca Bertinotti; Stefania Bracci; Francesca Nacci; Nicola Colangelo; Angela Del Rosso; Roberto Casale; Alberto Pignone; Marco Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2003-12-10       Impact factor: 2.980

Review 8.  The impact of rheumatic diseases on sexual function.

Authors:  Antonio G Tristano
Journal:  Rheumatol Int       Date:  2009-01-20       Impact factor: 2.631

Review 9.  Reproductive Issues and Pregnancy Implications in Systemic Sclerosis.

Authors:  Maria-Grazia Lazzaroni; Francesca Crisafulli; Liala Moschetti; Paolo Semeraro; Ana-Rita Cunha; Agna Neto; Andrea Lojacono; Francesca Ramazzotto; Cristina Zanardini; Sonia Zatti; Paolo Airò; Angela Tincani; Franco Franceschini; Laura Andreoli
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-18       Impact factor: 8.667

10.  Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group.

Authors:  Chingching Foocharoen; Alan Tyndall; Eric Hachulla; Edoardo Rosato; Yannick Allanore; Dominique Farge-Bancel; Paola Caramaschi; Paolo Airó; Starovojtova M Nikolaevna; José António Pereira da Silva; Bojana Stamenkovic; Gabriela Riemekasten; Simona Rednic; Jean Sibilia; Piotr Wiland; Ingo Tarner; Vanessa Smith; Anna T Onken; Walid Ahmed Abdel Atty Mohamed; Oliver Distler; Jadranka Morović-Vergles; Andrea Himsel; Paloma Garcia de la Peña Lefebvre; Thomas Hügle; Ulrich A Walker
Journal:  Arthritis Res Ther       Date:  2012-02-20       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.